| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.1 |